GapDB find and trade gaps by statistics
Biotech IBB+XBI 1Y Gap Scan
Updated 2019-12-11
click to sort
| Company | Symbol | TotalGap | FilledGap | UnfilledGap | UnfilledPct |
|---|---|---|---|---|---|
| Flexion Therapeutics Inc. | FLXN | 7 | 4 | 3 | 42.9 |
| ProQR Therapeutics N.V. | PRQR | 2 | 2 | 0 | 0 |
| Aptinyx Inc | APTX | 3 | 2 | 1 | 33.3 |
| Prothena Corp. Plc | PRTA | 5 | 3 | 2 | 40 |
| Momenta Pharmaceuticals Inc. | MNTA | 5 | 4 | 1 | 20 |
| CRISPR Therapeutics AG | CRSP | 9 | 6 | 3 | 33.3 |
| Biogen Inc. | BIIB | 6 | 4 | 2 | 33.3 |
| Magenta Therapeutics Inc | MGTA | 0 | 0 | 0 | 0 |
| Incyte Corporation | INCY | 7 | 6 | 1 | 14.3 |
| Rhythm Pharmaceuticals Inc. | RYTM | 3 | 3 | 0 | 0 |
| Crinetics Pharmaceuticals Inc | CRNX | 0 | 0 | 0 | 0 |
| OPKO Health Inc. | OPK | 2 | 2 | 0 | 0 |
| Karyopharm Therapeutics Inc. | KPTI | 7 | 5 | 2 | 28.6 |
| Arrowhead Pharmaceuticals Inc. | ARWR | 5 | 3 | 2 | 40 |
| MannKind Corporation | MNKD | 1 | 1 | 0 | 0 |
| PetIQ Inc. Class A | PETQ | 4 | 4 | 0 | 0 |
| Progenics Pharmaceuticals Inc. | PGNX | 3 | 2 | 1 | 33.3 |
| Paratek Pharmaceuticals Inc | PRTK | 0 | 0 | 0 | 0 |
| Wave Life Sciences Ltd. | WVE | 1 | 1 | 0 | 0 |
| Proteostasis Therapeutics Inc. | PTI | 2 | 0 | 2 | 100 |
| Xenon Pharmaceuticals Inc. | XENE | 5 | 5 | 0 | 0 |
| Exelixis Inc. | EXEL | 3 | 3 | 0 | 0 |
| PRA Health Sciences Inc. | PRAH | 5 | 5 | 0 | 0 |
| Zogenix Inc. | ZGNX | 3 | 3 | 0 | 0 |
| Pacira Biosciences Inc. | PCRX | 4 | 4 | 0 | 0 |
| EyePoint Pharmaceuticals Inc. | EYPT | 3 | 3 | 0 | 0 |
| Aimmune Therapeutics Inc | AIMT | 7 | 6 | 1 | 14.3 |
| Retrophin Inc. | RTRX | 1 | 1 | 0 | 0 |
| Apellis Pharmaceuticals Inc. | APLS | 2 | 2 | 0 | 0 |
| Adamas Pharmaceuticals Inc. | ADMS | 0 | 0 | 0 | 0 |
| Forty Seven Inc | FTSV | 2 | 1 | 1 | 50 |
| Coherus BioSciences Inc. | CHRS | 5 | 3 | 2 | 40 |
| Illumina Inc. | ILMN | 12 | 10 | 2 | 16.7 |
| Savara Inc. | SVRA | 2 | 1 | 1 | 50 |
| Arbutus Biopharma Corporation | ABUS | 2 | 0 | 2 | 100 |
| Neurocrine Biosciences Inc. | NBIX | 8 | 7 | 1 | 12.5 |
| Athenex Inc. | ATNX | 2 | 1 | 1 | 50 |
| UroGen Pharma Ltd. | URGN | 5 | 4 | 1 | 20 |
| Denali Therapeutics Inc. | DNLI | 3 | 3 | 0 | 0 |
| Rigel Pharmaceuticals Inc. | RIGL | 0 | 0 | 0 | 0 |
| Repligen Corporation | RGEN | 4 | 1 | 3 | 75 |
| Stemline Therapeutics Inc. | STML | 4 | 4 | 0 | 0 |
| Kura Oncology Inc. | KURA | 4 | 3 | 1 | 25 |
| Editas Medicine Inc. | EDIT | 6 | 5 | 1 | 16.7 |
| Cerus Corporation | CERS | 3 | 3 | 0 | 0 |
| Vertex Pharmaceuticals Incorporated | VRTX | 9 | 7 | 2 | 22.2 |
| Exact Sciences Corporation | EXAS | 7 | 6 | 1 | 14.3 |
| Unum Therapeutics Inc. | UMRX | 0 | 0 | 0 | 0 |
| Anika Therapeutics Inc. | ANIK | 5 | 2 | 3 | 60 |
| Esperion Therapeutics Inc. | ESPR | 6 | 5 | 1 | 16.7 |
| Aquestive Therapeutics Inc. | AQST | 4 | 2 | 2 | 50 |
| Alkermes Plc | ALKS | 9 | 9 | 0 | 0 |
| CymaBay Therapeutics Inc. | CBAY | 2 | 2 | 0 | 0 |
| Chemocentryx Inc. | CCXI | 3 | 2 | 1 | 33.3 |
| Dermira Inc | DERM | 7 | 4 | 3 | 42.9 |
| Geron Corporation | GERN | 4 | 3 | 1 | 25 |
| Lexicon Pharmaceuticals Inc. | LXRX | 1 | 0 | 1 | 100 |
| Mirati Therapeutics Inc. | MRTX | 8 | 6 | 2 | 25 |
| Bio-Techne Corporation | TECH | 2 | 2 | 0 | 0 |
| Foamix Pharmaceuticals Ltd. | FOMX | 3 | 2 | 1 | 33.3 |
| Kala Pharmaceuticals Inc. | KALA | 2 | 2 | 0 | 0 |
| Tocagen Inc. | TOCA | 1 | 1 | 0 | 0 |
| Spark Therapeutics Inc. | ONCE | 2 | 0 | 2 | 100 |
| Ionis Pharmaceuticals Inc. | IONS | 4 | 3 | 1 | 25 |
| Pacific Biosciences of California Inc. | PACB | 2 | 1 | 1 | 50 |
| resTORbio Inc. | TORC | 0 | 0 | 0 | 0 |
| Aeglea BioTherapeutics Inc | AGLE | 1 | 1 | 0 | 0 |
| Concert Pharmaceuticals Inc. | CNCE | 3 | 3 | 0 | 0 |
| United Therapeutics Corporation | UTHR | 3 | 2 | 1 | 33.3 |
| Vericel Corporation | VCEL | 6 | 4 | 2 | 33.3 |
| Amicus Therapeutics Inc. | FOLD | 5 | 5 | 0 | 0 |
| Insmed Incorporated | INSM | 5 | 3 | 2 | 40 |
| Adverum Biotechnologies Inc | ADVM | 3 | 1 | 2 | 66.7 |
| Homology Medicines Inc. | FIXX | 0 | 0 | 0 | 0 |
| Strongbridge Biopharma plc | SBBP | 0 | 0 | 0 | 0 |
| Aclaris Therapeutics Inc. | ACRS | 5 | 4 | 1 | 20 |
| AnaptysBio Inc. | ANAB | 6 | 5 | 1 | 16.7 |
| bluebird bio Inc. | BLUE | 9 | 9 | 0 | 0 |
| Akorn Inc. | AKRX | 2 | 2 | 0 | 0 |
| Atara Biotherapeutics Inc | ATRA | 5 | 5 | 0 | 0 |
| Allakos Inc. | ALLK | 5 | 2 | 3 | 60 |
| FibroGen Inc. | FGEN | 6 | 5 | 1 | 16.7 |
| AcelRx Pharmaceuticals Inc. | ACRX | 2 | 2 | 0 | 0 |
| Gilead Sciences Inc. | GILD | 9 | 9 | 0 | 0 |
| MacroGenics Inc. | MGNX | 5 | 5 | 0 | 0 |
| Reata Pharmaceuticals Inc. Class A | RETA | 4 | 2 | 2 | 50 |
| Ligand Pharmaceuticals Incorporated | LGND | 5 | 4 | 1 | 20 |
| Collegium Pharmaceutical Inc. | COLL | 3 | 1 | 2 | 66.7 |
| Ocular Therapeutix Inc | OCUL | 1 | 1 | 0 | 0 |
| Enanta Pharmaceuticals Inc. | ENTA | 3 | 3 | 0 | 0 |
| SIGA Technologies Inc | SIGA | 1 | 1 | 0 | 0 |
| Zafgen Inc. | ZFGN | 1 | 1 | 0 | 0 |
| Regeneron Pharmaceuticals Inc. | REGN | 4 | 3 | 1 | 25 |
| OptiNose Inc. | OPTN | 5 | 5 | 0 | 0 |
| Eidos Therapeutics Inc | EIDX | 3 | 1 | 2 | 66.7 |
| Aerie Pharmaceuticals Inc. | AERI | 4 | 4 | 0 | 0 |
| Xeris Pharmaceuticals Inc | XERS | 1 | 1 | 0 | 0 |
| NanoString Technologies Inc. | NSTG | 4 | 2 | 2 | 50 |
| Clovis Oncology Inc. | CLVS | 4 | 3 | 1 | 25 |
| Ironwood Pharmaceuticals Inc. Class A | IRWD | 1 | 1 | 0 | 0 |
| Intercept Pharmaceuticals Inc. | ICPT | 7 | 5 | 2 | 28.6 |
| MyoKardia Inc. | MYOK | 2 | 2 | 0 | 0 |
| G1 Therapeutics Inc. | GTHX | 3 | 3 | 0 | 0 |
| Alexion Pharmaceuticals Inc. | ALXN | 9 | 9 | 0 | 0 |
| Amphastar Pharmaceuticals Inc | AMPH | 5 | 5 | 0 | 0 |
| Eloxx Pharmaceuticals Inc. | ELOX | 0 | 0 | 0 | 0 |
| ImmunoGen Inc. | IMGN | 2 | 2 | 0 | 0 |
| Emergent BioSolutions Inc. | EBS | 4 | 2 | 2 | 50 |
| Nektar Therapeutics | NKTR | 6 | 6 | 0 | 0 |
| Tricida Inc | TCDA | 2 | 1 | 1 | 50 |
| AVROBIO Inc | AVRO | 3 | 3 | 0 | 0 |
| Eiger BioPharmaceuticals Inc. | EIGR | 2 | 2 | 0 | 0 |
| PTC Therapeutics Inc. | PTCT | 3 | 0 | 3 | 100 |
| Five Prime Therapeutics Inc. | FPRX | 2 | 2 | 0 | 0 |
| Spectrum Pharmaceuticals Inc. | SPPI | 3 | 3 | 0 | 0 |
| Luminex Corp | LMNX | 3 | 3 | 0 | 0 |
| AbbVie Inc. | ABBV | 8 | 8 | 0 | 0 |
| ACADIA Pharmaceuticals Inc. | ACAD | 4 | 2 | 2 | 50 |
| Aduro BioTech Inc. | ADRO | 1 | 1 | 0 | 0 |
| Sarepta Therapeutics Inc. | SRPT | 8 | 6 | 2 | 25 |
| Neuronetics Inc. | STIM | 1 | 1 | 0 | 0 |
| Seres Therapeutics Inc | MCRB | 2 | 2 | 0 | 0 |
| Epizyme Inc. | EPZM | 7 | 5 | 2 | 28.6 |
| Biohaven Pharmaceutical Holding Company Ltd. | BHVN | 2 | 2 | 0 | 0 |
| Allogene Therapeutics Inc. | ALLO | 5 | 4 | 1 | 20 |
| Kiniksa Pharmaceuticals Ltd. Class A | KNSA | 2 | 1 | 1 | 50 |
| AMAG Pharmaceuticals Inc. | AMAG | 3 | 3 | 0 | 0 |
| Veracyte Inc | VCYT | 4 | 4 | 0 | 0 |
| Madrigal Pharmaceuticals Inc. | MDGL | 3 | 2 | 1 | 33.3 |
| Acceleron Pharma Inc | XLRN | 2 | 2 | 0 | 0 |
| Heron Therapeutics Inc | HRTX | 5 | 5 | 0 | 0 |
| Sangamo Therapeutics Inc. | SGMO | 5 | 5 | 0 | 0 |
| Omeros Corporation | OMER | 5 | 5 | 0 | 0 |
| Fate Therapeutics Inc. | FATE | 5 | 4 | 1 | 20 |
| Audentes Therapeutics Inc. | BOLD | 6 | 4 | 2 | 33.3 |
| REGENXBIO Inc. | RGNX | 5 | 4 | 1 | 20 |
| Intra-Cellular Therapies Inc. | ITCI | 7 | 5 | 2 | 28.6 |
| CareDx Inc. | CDNA | 2 | 2 | 0 | 0 |
| PDL BioPharma Inc. | PDLI | 4 | 2 | 2 | 50 |
| Verastem Inc. | VSTM | 1 | 1 | 0 | 0 |
| Vanda Pharmaceuticals Inc. | VNDA | 5 | 2 | 3 | 60 |
| Syneos Health Inc. Class A | SYNH | 7 | 6 | 1 | 14.3 |
| uniQure N.V. | QURE | 8 | 6 | 2 | 25 |
| Mylan N.V. | MYL | 6 | 6 | 0 | 0 |
| Natera Inc. | NTRA | 3 | 2 | 1 | 33.3 |
| Synlogic Inc | SYBX | 3 | 3 | 0 | 0 |
| Novavax Inc. | NVAX | 5 | 4 | 1 | 20 |
| Akcea Therapeutics Inc. | AKCA | 3 | 2 | 1 | 33.3 |
| Inovio Pharmaceuticals Inc. | INO | 1 | 1 | 0 | 0 |
| Intrexon Corporation | XON | 4 | 3 | 1 | 25 |
| Medpace Holdings Inc. | MEDP | 9 | 6 | 3 | 33.3 |
| Endo International Plc | ENDP | 3 | 3 | 0 | 0 |
| TherapeuticsMD Inc. | TXMD | 1 | 1 | 0 | 0 |
| Halozyme Therapeutics Inc. | HALO | 2 | 2 | 0 | 0 |
| Invitae Corp. | NVTA | 7 | 5 | 2 | 28.6 |
| Ultragenyx Pharmaceutical Inc. | RARE | 2 | 2 | 0 | 0 |
| China Biologic Products Holdings Inc. | CBPO | 2 | 1 | 1 | 50 |
| Surface Oncology Inc. | SURF | 2 | 2 | 0 | 0 |
| Deciphera Pharmaceuticals Inc. | DCPH | 3 | 1 | 2 | 66.7 |
| Puma Biotechnology Inc. | PBYI | 2 | 2 | 0 | 0 |
| Minerva Neurosciences Inc | NERV | 4 | 4 | 0 | 0 |
| Dicerna Pharmaceuticals Inc. | DRNA | 4 | 2 | 2 | 50 |
| Twist Bioscience Corp. | TWST | 1 | 1 | 0 | 0 |
| Ra Pharmaceuticals Inc. | RARX | 1 | 0 | 1 | 100 |
| Catalyst Pharmaceuticals Inc. | CPRX | 2 | 2 | 0 | 0 |
| Quanterix Corporation | QTRX | 3 | 3 | 0 | 0 |
| Eagle Pharmaceuticals Inc. | EGRX | 7 | 5 | 2 | 28.6 |
| Amgen Inc. | AMGN | 10 | 6 | 4 | 40 |
| Acorda Therapeutics Inc. | ACOR | 0 | 0 | 0 | 0 |
| SAGE Therapeutics Inc. | SAGE | 4 | 4 | 0 | 0 |
| Axovant Gene Therapies Ltd. | AXGT | 7 | 7 | 0 | 0 |
| Alnylam Pharmaceuticals Inc | ALNY | 5 | 4 | 1 | 20 |
| Seattle Genetics Inc. | SGEN | 8 | 4 | 4 | 50 |
| Myriad Genetics Inc. | MYGN | 4 | 4 | 0 | 0 |
| CytomX Therapeutics Inc. | CTMX | 3 | 2 | 1 | 33.3 |
| Supernus Pharmaceuticals Inc. | SUPN | 3 | 3 | 0 | 0 |
| Rocket Pharmaceuticals Inc. | RCKT | 6 | 4 | 2 | 33.3 |
| Evolus Inc. | EOLS | 4 | 4 | 0 | 0 |
| Theravance Biopharma Inc | TBPH | 2 | 2 | 0 | 0 |
| Radius Health Inc | RDUS | 5 | 4 | 1 | 20 |
| Medicines Company | MDCO | 7 | 3 | 4 | 57.1 |
| Voyager Therapeutics Inc. | VYGR | 4 | 2 | 2 | 50 |
| Achillion Pharmaceuticals Inc. | ACHN | 3 | 1 | 2 | 66.7 |
| Rubius Therapeutics Inc. | RUBY | 1 | 1 | 0 | 0 |
| Turning Point Therapeutics Inc. | TPTX | 4 | 3 | 1 | 25 |
| Assertio Therapeutics Inc. | ASRT | 1 | 1 | 0 | 0 |
| ArQule Inc. | ARQL | 6 | 2 | 4 | 66.7 |
| BioCryst Pharmaceuticals Inc. | BCRX | 0 | 0 | 0 | 0 |
| Horizon Therapeutics Public Limited Company | HZNP | 3 | 1 | 2 | 66.7 |
| AC Immune SA | ACIU | 2 | 2 | 0 | 0 |
| Viking Therapeutics Inc. | VKTX | 3 | 3 | 0 | 0 |
| Aurinia Pharmaceuticals Inc. | AUPH | 5 | 2 | 3 | 60 |
| Intellia Therapeutics Inc. | NTLA | 5 | 3 | 2 | 40 |
| Cytokinetics Incorporated | CYTK | 5 | 4 | 1 | 20 |
| Revance Therapeutics Inc. | RVNC | 4 | 4 | 0 | 0 |
| Replimune Group Inc. | REPL | 4 | 4 | 0 | 0 |
| Jazz Pharmaceuticals Plc | JAZZ | 6 | 6 | 0 | 0 |
| Akebia Therapeutics Inc. | AKBA | 2 | 2 | 0 | 0 |
| ANI Pharmaceuticals Inc. | ANIP | 5 | 3 | 2 | 40 |
| Blueprint Medicines Corp. | BPMC | 5 | 4 | 1 | 20 |
| Krystal Biotech Inc. | KRYS | 2 | 1 | 1 | 50 |
| Iovance Biotherapeutics Inc | IOVA | 4 | 3 | 1 | 25 |
| Agios Pharmaceuticals Inc. | AGIO | 5 | 4 | 1 | 20 |
| MediciNova Inc. | MNOV | 21 | 20 | 1 | 4.8 |
| Global Blood Therapeutics Inc | GBT | 3 | 3 | 0 | 0 |
| Amyris Inc. | AMRS | 4 | 4 | 0 | 0 |
| Innoviva Inc. | INVA | 4 | 2 | 2 | 50 |
| Arena Pharmaceuticals Inc. | ARNA | 4 | 4 | 0 | 0 |
| Portola Pharmaceuticals Inc. | PTLA | 4 | 3 | 1 | 25 |
| TG Therapeutics Inc. | TGTX | 5 | 3 | 2 | 40 |
| Novocure Ltd. | NVCR | 7 | 5 | 2 | 28.6 |
| Translate Bio Inc. | TBIO | 0 | 0 | 0 | 0 |
| Immunomedics Inc. | IMMU | 2 | 1 | 1 | 50 |
| Syros Pharmaceuticals Inc. | SYRS | 1 | 1 | 0 | 0 |
| Xencor Inc. | XNCR | 4 | 4 | 0 | 0 |
| Cara Therapeutics Inc | CARA | 3 | 3 | 0 | 0 |
| Corbus Pharmaceuticals Holdings Inc | CRBP | 5 | 5 | 0 | 0 |
| ZIOPHARM Oncology Inc. | ZIOP | 2 | 1 | 1 | 50 |
| GlycoMimetics Inc. | GLYC | 3 | 3 | 0 | 0 |
| BioMarin Pharmaceutical Inc. | BMRN | 4 | 3 | 1 | 25 |
| Unity Biotechnology Inc. | UBX | 1 | 1 | 0 | 0 |
| Solid Biosciences Inc. | SLDB | 3 | 3 | 0 | 0 |
Gap Statistics:
Must-Read Books on Technical Analysis:
Japanese Candlestick Charting Techniques by Steve Nison
Technical Analysis of the Financial Markets by John Murphy
